Aziz A. Chentoufi0000-0002-5410-2593
Dr. Chentoufi is a consultant and Head of Immunology Department at KFMC. He is also Adjunct Associate Professor of Immunology at the King Saud Ibn AbdulAziz University FOM-KFMC. Dr. Chentoufi received his Ph.D. in BioMedical Sciences (Immunology) from the University Catholic of Louvain, Brussels, Belgium in 1999. Dr Chentoufi has done postdoctoral fellowship at McGill University, Montreal, Canada from 1999 to 2004 where he worked on immunogenetic of type 1 Diabetes and gene therapy for graft versus host disease. Then he was appointed as specialist at the University of California Irvine-Medical center, Irvine, California, USA in 2006 where he was a key investigator in the development of asymptomatic slef-adjuvanting mucosal vaccine construct against herpes simplex virus type 1 and 2. Dr. Chentoufi is an independent clinical immunologist, with a national and international reputation in vaccine development against both infectious and autoimmune diseases. Dr. Chentoufi is well integrated into the scientific community within the United States as well as Europe and Saudi Arabia; he is actively involved in a number of professional societies including Association of Clinical Scientist, Canadian Society of Immunology and The Federation of Clinical Immunology societies (FOCIS). Dr Chentoufi have several research proposals funded by Minster of Health, KACST and KFMC. Finally, Dr Chentoufi is associate editors in many scientific journals and has more than 40 publications in high impact factor journals.?
Biography Updated on 22 September 2013